Merck's Keytruda looks to zoom past Opdivo with fast head and neck cancer review

11th February 2019 Uncategorised 0

Merck’s Keytruda is duking it out with Bristol-Myers Squibb’s Opdivo in the head and neck cancer marketplace, but Keytruda just took one step toward a green light that would give it a big edge.

More: Merck's Keytruda looks to zoom past Opdivo with fast head and neck cancer review
Source: fierce